Henry Schein, Inc. · NASDAQ:HSIC
Henry Schein — J.P. Morgan Healthcare Conference 2026
8 slides from Henry Schein's conference presentation, Jan 13, 2026
Slide 1: JP Morgan Healthcare Conference
JP Morgan Healthcare Conference January 13, 2026
Slide 2: Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information
Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could ca
Slide 3: Fred Lowery
Fred Lowery “This is an organization with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service, and partnership. I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value
Slide 4: Henry Schein Overview
Henry Schein Overview #1 global provider of dental merchandise, specialty products, traditional and digital equipment, parts and services and a leading provider of medical products, equipment and services to the alternate care and home care markets with $3B+ in corporate and owned brands portfolio a
Slide 5: 2025 Highlights
2025 Highlights Market Conditions Business Highlights Value Creation Initiatives Sales growth accelerated in each of our Goal to deliver over $200 million of improvements Stable Dental market conditions reportable segments to operating income over the next few years in two key areas of focus: Medica
Slide 6: Long Term Growth Strategy
Long Term Growth Strategy Clear strategic framework to deliver sustainable value creation Global Distribution and Value- Global Specialty Products Global Technology Added Services • Increasing penetration with existing • Drive new development in owned brand • Continue to generate synergies with cust
Slide 7: Henry Schein Financial Overview
Henry Schein Financial Overview NON-GAAP OPERATING INCOME1 NON-GAAP EARNINGS PER DILUTED SHARE1 ($ IN MILLIONS) ($) $1,500 $6.00 $5.38 $1,038 $5.05 $1,000 $5.00 $999 $949 $4.74 $890 [2] $4.50 [2] $837 500 $769 $3.97 $4.00 $742 $690 $3.50 $3.52 $500 $3.11 $3.00 $0 2017 2018 2019 2020 2021 2022 2023 2
Slide 8: Investment Merits
Investment Merits • Clear strategic plan for growth • Proven track record of earnings growth • Leading positions in attractive markets • Scaled platform of highly complementary products, services and technologies • Opportunities to gain additional share of customer wallet • Deep and experienced mana
Henry Schein — J.P. Morgan Healthcare Conference 2026 on 6ix